Rapid Mortality Surveillance of COVID-19 Using Verbal Autopsy GHDx Entry last modified on: Dec 12, 2023
Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2: seroepidemiological pattern in northeastern Bulgaria GHDx Entry last modified on: Mar 14, 2022
Sero-surveillance (IgG) of SARS-CoV-2 among Asymptomatic General population of Paschim Medinipur District, West Bengal, India. Preprint. GHDx Entry last modified on: Mar 14, 2022
Problematic internet use and suicidality and self-injurious behaviors in adolescents: Effects of negative affectivity and social support GHDx Entry last modified on: Mar 22, 2024
Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020 GHDx Entry last modified on: Jan 31, 2024
New onset neurologic events in people with COVID-19 in 3 regions in China GHDx Entry last modified on: Jan 31, 2024
Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19 GHDx Entry last modified on: Mar 14, 2022
Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth GHDx Entry last modified on: Mar 14, 2022
Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App GHDx Entry last modified on: Apr 10, 2023
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery GHDx Entry last modified on: Jan 31, 2024
COVID-19 in pregnancy: A preliminary 50-day review from India GHDx Entry last modified on: Jan 31, 2024
COVID-19 mortality among pregnant women in Mexico: A retrospective cohort study GHDx Entry last modified on: Apr 10, 2023
Preterm birth among women with and without severe acute respiratory syndrome coronavirus 2 infection GHDx Entry last modified on: Jan 31, 2024
The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS) GHDx Entry last modified on: Apr 10, 2023
Mental distress among U.S. adults during the COVID-19 pandemic GHDx Entry last modified on: Mar 14, 2022
Depression, risk factors, and coping strategies in the context of social dislocations resulting from the second wave of COVID-19 in Japan GHDx Entry last modified on: Mar 14, 2022
COVID-19 and Depressive Symptoms: A Community-based Study in Quebec, Canada GHDx Entry last modified on: Jan 31, 2024
Malaria epidemiology and stratification of incidence in the malaria elimination settingin Harari Region, Eastern Ethiopia GHDx Entry last modified on: Apr 10, 2023
[The experience of the study of seroprevalence to the SARS-CoV-2 virus in the population of the Irkutsk region during the COVID-19 outbreak] Опыт исс ледования серопревалентности к вирусу SARS-CoV-2 населения Иркутск ой области в период вспышки COVID-19 GHDx Entry last modified on: Mar 14, 2022
A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms. Preprint GHDx Entry last modified on: Jun 18, 2021
Coronavirus disease 2019 population-based prevalence, risk factors, hospitalization, and fatality rates in southern Brazil GHDx Entry last modified on: Mar 14, 2022
Impact of the COVID-19 Pandemic on Cancer Diagnoses in General and Specialized Practices in Germany GHDx Entry last modified on: Apr 10, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Universal Testing Experience on a Los Angeles Labor and Delivery Unit GHDx Entry last modified on: Jan 31, 2024
A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population GHDx Entry last modified on: Jan 31, 2024
Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands GHDx Entry last modified on: Apr 10, 2023
Trends of SARS-CoV-2 antibody prevalence in selected regions across Ghana. Preprint GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020 GHDx Entry last modified on: May 12, 2022
Factors Associated with the Development of Childhood Asthma in Japan: A Nationwide Longitudinal Study GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district of Cameroon. Preprint GHDx Entry last modified on: May 12, 2022
Long COVID in children and adolescents: COVID-19 follow-up results in third-level pediatric hospital GHDx Entry last modified on: Mar 22, 2024
Serological Biomarkers at Hospital Admission Are Not Related to Long-Term Post-COVID Fatigue and Dyspnea in COVID-19 Survivors GHDx Entry last modified on: Mar 22, 2024
Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndrome GHDx Entry last modified on: Mar 22, 2024
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021 GHDx Entry last modified on: Mar 14, 2022
One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study GHDx Entry last modified on: Mar 22, 2024
SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital GHDx Entry last modified on: Mar 14, 2022
Twelve-month follow-up after hospitalization for SARS-COV-2: Physiology improves, symptoms remain GHDx Entry last modified on: Mar 22, 2024
Prevalence of Severe Acute Respiratory Syndrome Coronavirus-2-specific Antibodies in German Blood Donors during the COVID-19 Pandemic GHDx Entry last modified on: Jan 31, 2024
Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge GHDx Entry last modified on: Mar 22, 2024
Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey GHDx Entry last modified on: Jan 31, 2024
Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India GHDx Entry last modified on: Jan 31, 2024
High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary Results GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China GHDx Entry last modified on: Mar 14, 2022
Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults. Preprint GHDx Entry last modified on: Mar 14, 2022
Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020 GHDx Entry last modified on: Mar 14, 2022
Direct and indirect predictors of postpartum depression symptoms among indigenous Bedouin mothers in Israel GHDx Entry last modified on: Mar 22, 2024
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence in Blood in a Large School Community Subject to a Coronavirus Disease 2019 Outbreak: A Cross-sectional Study GHDx Entry last modified on: Mar 14, 2022
Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China GHDx Entry last modified on: Jan 31, 2024